ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Bear of the Day: Eli Lilly (LLY)
Eli Lilly & Company LLY announced its financial guidance for 2023 on December 13. Shares have traded down since then as the company’s 2023 earnings projections were below analyst expectations.But the stock had some room to give back. This year, L
Announcement as on 10 January 2023

Bear of the Day: Eli Lilly (LLY)
Eli Lilly & Company LLY announced its financial guidance for 2023 on December 13. Shares have traded down since then as the company’s 2023 earnings projections were below analyst expectations.But the stock had some room to give back. This year, L
Announcement as on 10 January 2023

Eli Lilly sets guidance for 2023 and stock falls as EPS lags current consensus
Eli Lilly & Co. announced guidance for 2023 on Tuesday and highlighted potential launches for a series of treatments, including a potential regulatory submission for its much-anticipated obesity treatment tirzepatide. The company said it expects per-share
Announcement as on 13 December 2022

Eli Lilly introduces medication for early stage breast cancer
In India, over 50,000 patients are diagnosed with early breast cancer (EBC) every year. Breast cancer is the cancer which is most prevalent amongst women in India. It significantly impacts the quality of life of survivors and their families, who live with
Announcement as on 24 November 2022

Eli Lilly to acquire Akouos for up to about 0 million and develop gene therapies for hearing loss
Eli Lilly and Co. said Tuesday it has entered an agreement to acquire Akouos Inc. , a company developing a portfolio of viral gene therapies for the treatment of inner ear conditions including hearing loss, for up to 0 million in cash. Under the terms
Announcement as on 18 October 2022

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1327.38
  • 12Day Average: 1293.9
  • 20Day Average: 1246.19
  • 50Day Average: 1197.21
  • 100Day Average: 1187.89
  • 150Day Average: 1121.89
  • 200Day Average: 1092.51

LLY Indicators & signals

Indicator MACD (12,26,9)

1297.95, 1250.96, 32.05
Indicator MACD is in positive zone

Indicator ADX (14)

63.73, 42.33, 9.38
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 1414.92 1382.29 to 1449.68 3.05% 1.39 times
29 Thu Oct 2026 1373.00 1330.00 to 1408.38 6.57% 1.63 times
28 Wed Oct 2026 1288.30 1260.34 to 1299.43 0.53% 1.14 times
27 Tue Oct 2026 1281.52 1270.00 to 1297.92 0.19% 0.47 times
26 Mon Oct 2026 1279.14 1273.73 to 1296.90 0.45% 1.17 times
23 Fri Oct 2026 1273.46 1257.62 to 1307.92 -2.55% 1.27 times
22 Thu Oct 2026 1306.74 1275.10 to 1321.21 2.7% 0.85 times
21 Wed Oct 2026 1272.40 1261.08 to 1279.28 -1.12% 0.52 times
20 Tue Oct 2026 1286.83 1260.17 to 1311.75 3.62% 1.19 times
19 Mon Oct 2026 1241.82 1239.10 to 1259.75 -1.21% 0.42 times
16 Fri Oct 2026 1257.03 1251.25 to 1274.56 0.43% 1.34 times
15 Thu Oct 2026 1251.61 1230.66 to 1275.88 3.55% 2.09 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

 

Back to top